NanoString Technologies Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2022 / 11:00PM GMT
Tycho W. Peterson - JPMorgan Chase & Co., Research Division - Senior Analyst

All right. Good afternoon. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this afternoon, NanoString. Just a quick reminder, you can submit questions through the website. With that, I'll turn it over to Brad.

R. Bradley Gray - NanoString Technologies, Inc. - CEO, President & Director

Thanks for having us, Tycho, and it's great to be here. Over the next 20 minutes, I hope to do 3 things. One is reintroduce NanoString and the idea of Spatial Biology. Two is, recap a really strong finish to 2021. And three is, preview some of the exciting activities and news flow coming in 2022.

I will be making forward-looking statements, and I will refer you to our SEC filings for risk factors. Let me start with NanoString's company profile.

We're a Seattle-based provider of life science tools. Our products have delighted customers in advanced science for more than a decade. Today, we have 3 major platforms with over 5,000 peer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot